Literature DB >> 2943410

Concurrent enhancement of monocyte immunoregulatory properties and effector functions by recombinant interferon-gamma.

D J Tweardy, H Fujiwara, J J Scillian, J J Ellner.   

Abstract

Interferon-gamma is a critical factor in the activation of several mononuclear phagocyte effector and immunoregulatory properties. However, it remains uncertain if IFN-gamma is capable of concurrent activation of both functions in the same cell population. Plastic adherent mononuclear cells (80-98% MN by cytochemical criteria) were cultivated in the absence or presence of recombinant interferon-gamma (rIFN-gamma, 0.1-100 U/ml) for 48 hr. MN surface DR antigen was assessed by flow cytometry (EPICS V) after staining with monoclonal antibodies OKIa1 or L243. Exposure to rIFN-gamma (100 U/ml) increased MN surface DR antigen (mean fluorescence intensity) by 80 +/- 20% (P less than 0.01) and 121 +/- 52% (P less than 0.001), respectively, compared to untreated cells. The increase in DR antigen was maximal at 100 U/ml, dependent on protein and RNA synthesis and blocked by agents that increase cAMP levels. IL-1 activity was determined in the mouse thymocyte assay; rIFN-gamma (100 U/ml) increased IL-1 activity in the supernatants of MN cultured in medium alone from 0.5 +/- 0.2 to 7.8 +/- 4.7 U/ml (P less than 0.05), and lipopolysaccharide-stimulated MN from 20.4 +/- 19.1 to 71.7 +/- 38.9 U/ml (P less than 0.05). Following rIFN-gamma exposure, MN stimulation of the AMLR was increased at 6 days (29,269 +/- 5224 vs 13,252 +/- 4938 cpm, P less than 0.01). Spontaneous cytotoxicity (SC) and antibody-dependent cell cytotoxicity (ADCC) were studied in a 51Cr release microculture assay using the human lymphoblastoid cell line CCRF-CEM as target. SC by MN increased linearly as a function of log[rIFN-gamma] for effector:target (E:T) ratios of 5:1 (r = 0.95, P less than 0.01) and 10:1 (r = 0.99, P less than 0.01). ADCC by MN increased following rIFN-gamma exposure (100 U/ml) at E:T ratios of 5:1 (22 +/- 13 to 31 +/- 4%, P less than 0.025) and 10:1 (31 +/- 4 to 38 +/- 4%, P less than 0.01). Thus, rIFN-gamma not only activates MN effector function, but has concurrent stimulatory effects on multiple MN properties critical to immunoregulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943410     DOI: 10.1016/0008-8749(86)90004-3

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  6 in total

1.  Stimulation of neutrophil respiratory burst and lysosomal enzyme release by human interferon-gamma.

Authors:  I C Kowanko; A Ferrante
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

2.  Effect of in vivo administration of recombinant murine gamma interferon on in vitro lymphoproliferative responses following immunization with Candida albicans.

Authors:  R E Garner; U Kuruganti; L A al-Hussaini; C W Czarniecki; J E Domer
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

3.  A phase II trial of murine monoclonal antibody 17-1A and interferon-gamma: clinical and immunological data.

Authors:  M N Saleh; A F LoBuglio; R H Wheeler; K J Rogers; A Haynes; J Y Lee; M B Khazaeli
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  Enhanced human monocyte cytotoxicity by platelet-activating factor.

Authors:  F H Valone; R Philip; R J Debs
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

5.  Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes.

Authors:  P H Hart; G A Whitty; D S Piccoli; J A Hamilton
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

6.  Impaired local natural killer cell activity in human colorectal carcinomas.

Authors:  N M Aparicio-Pagés; H W Verspaget; S A Peña; C B Lamers
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.